お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
980919

神経リハビリテーション装置の世界市場:2021年~2028年の予測

Global Neurorehabilitation Device Market Forecast 2021-2028

出版日: | 発行: Inkwood Research | ページ情報: 英文 205 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=107.49円
神経リハビリテーション装置の世界市場:2021年~2028年の予測
出版日: 2021年01月11日
発行: Inkwood Research
ページ情報: 英文 205 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の神経リハビリテーションデバイス市場は、2021年から2028年の予測期間に15.12%のCAGRで成長すると予測されています。同市場の成長は主に、高齢人口の増加、技術の進歩、神経リハビリテーションウェアラブルとロボット工学の進展、神経疾患の大幅な増加などの要因によるものです。

当レポートは、世界の神経リハビリテーション装置市場について調査しており、市場規模や推計、成長および抑制要因、COVID-19パンデミックの影響、製品・用途・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査範囲と調査手法

第2章 エグゼクティブサマリー

  • 市場規模・推計
  • 市場概要

第3章 市場力学

  • 主な成長要因
    • 高齢人口の増加
    • 神経リハビリテーションウェアラブルとロボット工学の進展
    • 神経疾患の著しい増加
    • 技術の進歩
  • 主な抑制要因
    • 熟練した専門家の不足
    • 高い治療費
    • 厳格な規制

第4章 主な分析

  • ポーターのファイブフォース分析
  • COVID-19が市場に与える影響
  • サプライチェーン分析
  • 神経リハビリテーション装置のタイムライン
  • 主な購入基準
  • オポチュニティマトリックス
  • ベンダー情勢
  • 主な投資洞察

第5章 市場分析:製品別

  • 神経ロボットシステム
  • ブレインコンピュータインターフェース
  • ウェアラブルデバイス
  • 非侵襲的刺激装置
  • その他

第6章 市場分析:用途別

  • 脳卒中
  • 脳性麻痺
  • パーキンソン病
  • 多発性硬化症
  • その他

第7章 市場分析:エンドユーザー別

  • 病院/クリニック
  • 研究機関
  • コグニティブケアセンター
  • その他

第8章 地域分析

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第9章 競合情勢

  • 主な戦略的開発
    • 合併と買収
    • 製品の発売と開発
    • 提携、契約/契約および協業
    • 事業拡大/承認/発表
  • 企業プロファイル
    • ABBOTT LABORATORIES
    • BIOMETRICS LTD
    • BIONIK LABORATORIES CORP
    • BIOXTREME
    • ECTRON LIMITED
    • EKSO BIONICS HOLDINGS INC
    • HELIUS MEDICAL TECHNOLOGIES
    • HOCOMA AG
    • KINESTICA
    • KINOVA
    • MEDTRONIC INC
    • NEUROSTYLE PTE LTD
    • TYROMOTION GMBH
図表

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - NEUROREHABILITATION DEVICE
  • TABLE 2: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 3: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 4: GLOBAL NEURO-ROBOTIC SYSTEM MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 5: GLOBAL NEURO-ROBOTIC SYSTEM MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 6: GLOBAL BRAIN COMPUTER INTERFACE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 7: GLOBAL BRAIN COMPUTER INTERFACE MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 8: GLOBAL WEARABLE DEVICE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 9: GLOBAL WEARABLE DEVICE MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 10: GLOBAL NON-INVASIVE STIMULATOR MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 11: GLOBAL NON-INVASIVE STIMULATOR MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 12: GLOBAL OTHER PRODUCTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 13: GLOBAL OTHER PRODUCTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 14: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 15: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 16: GLOBAL STROKE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 17: GLOBAL STROKE MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 18: GLOBAL CEREBRAL PALSY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 19: GLOBAL CEREBRAL PALSY MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 20: GLOBAL PARKINSON'S DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 21: GLOBAL PARKINSON'S DISEASE MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 22: GLOBAL MULTIPLE SCLEROSIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 23: GLOBAL MULTIPLE SCLEROSIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 24: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 25: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 26: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 27: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY END-USER, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 28: GLOBAL HOSPITALS/CLINIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 29: GLOBAL HOSPITALS/CLINIC MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 30: GLOBAL RESEARCH INSTITUTE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 31: GLOBAL RESEARCH INSTITUTE MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 32: GLOBAL COGNITIVE CARE CENTER MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 33: GLOBAL COGNITIVE CARE CENTER MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 34: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 35: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 36: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2020 ($ MILLION)
  • TABLE 37: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY GEOGRAPHY, FORECAST YEARS, 2021-2028 ($ MILLION)
  • TABLE 38: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 39: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 40: LEADING PLAYERS OPERATING IN NORTH AMERICA NEUROREHABILITATION DEVICE MARKET
  • TABLE 41: EUROPE NEUROREHABILITATION DEVICE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 42: EUROPE NEUROREHABILITATION DEVICE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 43: LEADING PLAYERS OPERATING IN EUROPE NEUROREHABILITATION DEVICE MARKET
  • TABLE 44: ASIA PACIFIC NEUROREHABILITATION DEVICE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 45: ASIA PACIFIC NEUROREHABILITATION DEVICE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 46: LEADING PLAYERS OPERATING IN ASIA PACIFIC NEUROREHABILITATION DEVICE MARKET
  • TABLE 47: REST OF WORLD NEUROREHABILITATION DEVICE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 48: REST OF WORLD NEUROREHABILITATION DEVICE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 49: LEADING PLAYERS OPERATING IN REST OF WORLD NEUROREHABILITATION DEVICE MARKET

LIST OF FIGURES

  • FIGURE 1: PREVALENCE OF ALZHEIMER'S DISEASE IN THE UNITED STATES, AGE WISE, 2019 (%)
  • FIGURE 2: NUMBER OF ELDERLY POPULACE, BY GEOGRAPHY (IN MILLION)
  • FIGURE 3: INCREASE IN THE PREVALENCE OF PARKINSON'S DISEASE GLOBALLY (IN MILLION)
  • FIGURE 4: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 5: TIMELINE OF NEUROREHABILITATION DEVICE MARKET
  • FIGURE 6: OPPORTUNITY MATRIX
  • FIGURE 7: VENDOR LANDSCAPE
  • FIGURE 8: KEY INVESTMENT INSIGHTS
  • FIGURE 9: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY PRODUCT, IN 2020
  • FIGURE 10: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY NEURO-ROBOTIC SYSTEM, 2021-2028 ($ MILLION)
  • FIGURE 11: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY BRAIN COMPUTER INTERFACE, 2021-2028 ($ MILLION)
  • FIGURE 12: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY WEARABLE DEVICE, 2021-2028 ($ MILLION)
  • FIGURE 13: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY NON-INVASIVE STIMULATOR, 2021-2028 ($ MILLION)
  • FIGURE 14: GLOBAL NEUROREHABILITATION DEVICE MARKET BY, OTHER PRODUCTS, 2021-2028 ($ MILLION)
  • FIGURE 15: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY APPLICATION, IN 2020
  • FIGURE 16: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY STROKE, 2021-2028 ($ MILLION)
  • FIGURE 17: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY CEREBRAL PALSY, 2021-2028 ($ MILLION)
  • FIGURE 18: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY PARKINSON'S DISEASE, 2021-2028 ($ MILLION)
  • FIGURE 19: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY MULTIPLE SCLEROSIS, 2021-2028 ($ MILLION)
  • FIGURE 20: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY OTHER APPLICATIONS, 2021-2028 ($ MILLION)
  • FIGURE 21: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY END-USER, IN 2020
  • FIGURE 22: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY HOSPITAL/CLINIC, 2021-2028 ($ MILLION)
  • FIGURE 23: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY RESEARCH INSTITUTE, 2021-2028 ($ MILLION)
  • FIGURE 24: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY COGNITIVE CARE CENTER, 2021-2028 ($ MILLION)
  • FIGURE 25: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY OTHER END-USERS, 2021-2028 ($ MILLION)
  • FIGURE 26: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 27: UNITED STATES NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)
  • FIGURE 28: CANADA NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)
  • FIGURE 29: EUROPE NEUROREHABILITATION DEVICE MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 30: GERMANY NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)
  • FIGURE 31: FRANCE NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)
  • FIGURE 32: UNITED KINGDOM NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)
  • FIGURE 33: ITALY NEUROREHABILITATION DEVICE MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 34: RUSSIA NEUROREHABILITATION DEVICE MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 35: BELGIUM NEUROREHABILITATION DEVICE MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 36: POLAND NEUROREHABILITATION DEVICE MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 37: REST OF EUROPE NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)
  • FIGURE 38: ASIA PACIFIC NEUROREHABILITATION DEVICE MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 39: CHINA NEURO REHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)
  • FIGURE 40: JAPAN NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)
  • FIGURE 41: AUSTRALIA & NEW ZEALAND NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)
  • FIGURE 42: INDIA NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)
  • FIGURE 43: SOUTH KOREA NEUROREHABILITATION DEVICE MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 44: THAILAND NEUROREHABILITATION DEVICE MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 45: INDONESIA NEUROREHABILITATION DEVICE MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 46: VIETNAM NEUROREHABILITATION DEVICE MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 47: REST OF ASIA PACIFIC NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)
  • FIGURE 48: REST OF WORLD NEUROREHABILITATION DEVICE MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 49: LATIN AMERICA NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)
  • FIGURE 50: MIDDLE EAST & AFRICA NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)
目次
Product Code: 17581

KEY FINDINGS

The global neurorehabilitation device market is expected to grow with a CAGR of 15.12%, over the forecast period of 2021 to 2028. The market growth is mainly accredited to factors, including the rising elderly population, technological advancements, the significant increase in neurological diseases, and surging neurorehabilitation wearable and robotics.

MARKET INSIGHTS

Neurological rehabilitation, also termed neurorehabilitation, is an essential part of the recovery process of patients who have sustained a brain injury. It aims to facilitate recovery, reduce symptoms, enhance function, and improve patients' well-being, who have experienced trauma to the nervous system.

The growing incidence of neurological diseases, such as, migraine, Alzheimer's disease, brain stroke, epilepsy, Parkinson's, neurodegeneration, and multiple sclerosis, among others, has resulted in the increased adoption of neurological devices for diagnosing and treating them. As per the World Health Organization (WHO), nearly 6 million deaths occur due to strokes, annually. Likewise, the WHO also states that epilepsy is a common neurological disease, with around 50 million individuals affected, and 2.4 million diagnosed with the condition, every year.

REGIONAL INSIGHTS

The global neurorehabilitation device market growth analysis includes the assessment of the Asia Pacific, North America, Europe, and the rest of the world. North America is anticipated to dominate the global market. Its growth is supplemented by the increasing elderly population, thereby creating an increased incidence of Alzheimer's and Parkinson's disease, federal government funding, and the rising investments for diagnosing and preventing neurogenerative conditions.

COMPETITIVE INSIGHTS

The intensity of competitive rivalry across the global neurorehabilitation market is projected to remain high over the forecast years. Moreover, the market is highly consolidated. Some of the key players operating in the market include, Medtronic PLC, Abbott Laboratories, Ekso Bionics Holdings, Hocoma AG, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. GROWING ELDERLY POPULACE
    • 3.1.2. GROWING NEUROREHABILITATION WEARABLES AND ROBOTICS
    • 3.1.3. SIGNIFICANT RISE IN NEUROLOGICAL DISEASES
    • 3.1.4. TECHNOLOGICAL ADVANCEMENTS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. DEARTH OF SKILLED SPECIALISTS
    • 3.2.2. HIGH COST OF TREATMENT
    • 3.2.3. STRINGENT REGULATIONS

4. KEY ANALYTICALS

  • 4.1. PORTER'S FIVE FORCES ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRANTS
    • 4.1.2. THREAT OF SUBSTITUTES
    • 4.1.3. BARGAINING POWER OF BUYER
    • 4.1.4. BARGAINING POWER OF SUPPLIER
    • 4.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 4.2. IMPACT OF COVID-19 ON NEUROREHABILITATION DEVICE MARKET
  • 4.3. SUPPLY CHAIN ANALYSIS
  • 4.4. TIMELINE OF NEUROREHABILITATION DEVICE
  • 4.5. KEY BUYING CRITERIA
  • 4.6. OPPORTUNITY MATRIX
  • 4.7. VENDOR LANDSCAPE
  • 4.8. KEY INVESTMENT INSIGHTS

5. MARKET BY PRODUCT

  • 5.1. NEURO-ROBOTIC SYSTEM
  • 5.2. BRAIN COMPUTER INTERFACE
  • 5.3. WEARABLE DEVICE
  • 5.4. NON-INVASIVE STIMULATOR
  • 5.5. OTHER PRODUCTS

6. MARKET BY APPLICATION

  • 6.1. STROKE
  • 6.2. CEREBRAL PALSY
  • 6.3. PARKINSON'S DISEASE
  • 6.4. MULTIPLE SCLEROSIS
  • 6.5. OTHER APPLICATIONS

7. MARKET BY END-USER

  • 7.1. HOSPITAL/CLINIC
  • 7.2. RESEARCH INSTITUTE
  • 7.3. COGNITIVE CARE CENTER
  • 7.4. OTHER END-USERS

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. MARKET SIZE & ESTIMATES
    • 8.1.2. KEY GROWTH ENABLERS
    • 8.1.3. KEY CHALLENGES
    • 8.1.4. KEY PLAYERS
    • 8.1.5. COUNTRY ANALYSIS
      • 8.1.5.1. UNITED STATES
      • 8.1.5.2. CANADA
  • 8.2. EUROPE
    • 8.2.1. MARKET SIZE & ESTIMATES
    • 8.2.2. KEY GROWTH ENABLERS
    • 8.2.3. KEY CHALLENGES
    • 8.2.4. KEY PLAYERS
    • 8.2.5. COUNTRY ANALYSIS
      • 8.2.5.1. GERMANY
      • 8.2.5.2. FRANCE
      • 8.2.5.3. UNITED KINGDOM
      • 8.2.5.4. ITALY
      • 8.2.5.5. RUSSIA
      • 8.2.5.6. BELGIUM
      • 8.2.5.7. POLAND
      • 8.2.5.8. REST OF EUROPE
  • 8.3. ASIA PACIFIC
    • 8.3.1. MARKET SIZE & ESTIMATES
    • 8.3.2. KEY GROWTH ENABLERS
    • 8.3.3. KEY CHALLENGES
    • 8.3.4. KEY PLAYERS
    • 8.3.5. COUNTRY ANALYSIS
      • 8.3.5.1. CHINA
      • 8.3.5.2. JAPAN
      • 8.3.5.3. AUSTRALIA & NEW ZEALAND
      • 8.3.5.4. INDIA
      • 8.3.5.5. SOUTH KOREA
      • 8.3.5.6. THAILAND
      • 8.3.5.7. INDONESIA
      • 8.3.5.8. VIETNAM
      • 8.3.5.9. REST OF ASIA PACIFIC
  • 8.4. REST OF WORLD
    • 8.4.1. MARKET SIZE & ESTIMATES
    • 8.4.2. KEY GROWTH ENABLERS
    • 8.4.3. KEY CHALLENGES
    • 8.4.4. KEY PLAYERS
    • 8.4.5. REGIONAL ANALYSIS
      • 8.4.5.1. LATIN AMERICA
      • 8.4.5.2. MIDDLE EAST & AFRICA

9. COMPETITIVE LANDSCAPE

  • 9.1. KEY STRATEGIC DEVELOPMENTS
    • 9.1.1. MERGER & ACQUISITIONS
    • 9.1.2. PRODUCT LAUNCH & DEVELOPMENTS
    • 9.1.3. PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
    • 9.1.4. BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
  • 9.2. COMPANY PROFILES
    • 9.2.1. ABBOTT LABORATORIES
    • 9.2.2. BIOMETRICS LTD
    • 9.2.3. BIONIK LABORATORIES CORP
    • 9.2.4. BIOXTREME
    • 9.2.5. ECTRON LIMITED
    • 9.2.6. EKSO BIONICS HOLDINGS INC
    • 9.2.7. HELIUS MEDICAL TECHNOLOGIES
    • 9.2.8. HOCOMA AG
    • 9.2.9. KINESTICA
    • 9.2.10. KINOVA
    • 9.2.11. MEDTRONIC INC
    • 9.2.12. NEUROSTYLE PTE LTD
    • 9.2.13. TYROMOTION GMBH
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.